Brain stimulation to ease pain and fatigue after COVID
Part of Bones, joints & muscles, Immune system & allergy, Skin clinical trials.
This study tests whether a noninvasive brain stimulation treatment can reduce fatigue and body pains after COVID in people with autoimmune diseases. It may help symptoms by changing brain activity without surgery.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have an autoimmune disease such as rheumatoid arthritis, lupus, Sjögren syndrome, spondyloarthritis, systemic sclerosis, systemic vasculitis, or autoimmune muscle disease
- You are recovering from COVID (post-acute stage)
- You currently have fatigue and/or general body pains
- You do not have a current or past cancer diagnosis (neoplasia)
- You do not have devices or metal in your body that could interfere, such as a heart pacemaker or internal metal clips
- You do not have certain infections (HIV, HTLV-1, or hepatitis), and you are not pregnant; you also have no history of seizures or epilepsy
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether a noninvasive brain stimulation treatment can help people with systemic autoimmune muscle diseases. It may improve symptoms by changing how the brain and muscles communicate.
This trial tests whether a noninvasive brain stimulation technique (through the scalp) can improve muscle weakness in people with certain autoimmune muscle diseases. It may help by changing brain signals that affect how muscles work.
This study tests whether a gentle, non-invasive brain stimulation technique (transcranial direct current stimulation) can help relieve brain fog and fatigue in people with long COVID. If you qualify, you would receive several sessions of the stimulation over a few weeks.
This study tests if a non-invasive brain stimulation technique can reduce pain in people with chronic pain conditions like fibromyalgia, headaches, or pain that started after COVID-19. It is looking for healthy people and people with ongoing pain to see if the treatment helps.
This trial tests if a gentle, home-based brain stimulation device (tDCS) can reduce chronic pain in people with rheumatoid arthritis who have low inflammation. It may offer a drug-free way to manage pain.
This trial tests a non-invasive brain stimulation method called Transcranial Pulse Stimulation (TPS) to see if it can help people with lingering post-COVID symptoms like fatigue and brain fog. If you've had COVID-19 and still have symptoms for at least 12 months, this study might be an option for you.
Hear when a new Rheumatic Diseases trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.